J. Bluestone

发表

Islet Transplantation in Type 1 Diabetics Using an Immunosuppressive Protocol Based on the Anti‐LFA‐1 Antibody Efalizumab

U. Masharani, A. Posselt, M. Bellin, 2010, American Journal of Transplantation.

The Effect of Costimulatory and Interleukin 2 Receptor Blockade on Regulatory T Cells in Renal Transplantation

J. Bluestone, A. Putnam, F. Vincenti, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.

J. Bluestone, A. Sharpe, A. Schweitzer, 1995, Immunity.

In vivo T-cell activation by staphylococcal enterotoxin B prevents outgrowth of a malignant tumor.

J. Bluestone, D. Bruce, K. Newell, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance

J. Bluestone, D. Sachs, S. Wren, 1985, The Journal of experimental medicine.

Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease Therapy

Jamie B. Spangler, V. Pande, K. Garcia, 2018, The Journal of Immunology.

The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes

Stanley J Tamaki, Jonathan H. Esensten, M. Spitzer, 2021 .

TITLEEngineering a single-agent cytokine-antibody fusion that selectively expands regulatory T cells for autoimmune disease therapy. AUTHORS

Petra Votavová, E. Trotta, J. Tomala, 2018 .

Ly-6C is a marker of memory CD8+ T cells.

J. Bluestone, D. Loh, T. Walunas, 1995, Journal of immunology.

Junctional sequences influence the specificity of gamma/delta T cell receptors

J. Bluestone, B. Rellahan, B. Houlden, 1991, The Journal of experimental medicine.

T Cell Receptor–γ/δ Cells Protect Mice from Herpes Simplex Virus Type 1–induced Lethal Encephalitis

J. Bluestone, R. Sciammas, R. Hendricks, 1997, The Journal of experimental medicine.

Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses.

J. Bluestone, H. Auchincloss, D. Sachs, 1988, Journal of immunology.

Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation.

J. Bluestone, K. Herold, J. Lu, 1997, Journal of immunology.

Realization of the therapeutic potential of CTLA-4 blockade in low-dose chemotherapy-treated tumor-bearing mice.

J. Bluestone, L. Gorelik, T. Kalinichenko, 1998, Cancer research.

Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies.

G. Freeman, J. Bluestone, D. Lenschow, 1995, Transplantation.

Characterization of T cell receptor gamma chain expression in a subset of murine thymocytes.

J. Coligan, R. Germain, J. Bluestone, 1986, Science.

Reduction of morbidity and cytokine release in anti-CD3 MoAb-treated mice by corticosteroids.

L. Chatenoud, S. Merite, Jean-François Bach, 1990, Transplantation.

CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation.

J. Bluestone, C. Thompson, J. Auger, 1996, Journal of immunology.

Anti-CD3 F(ab')2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb.

J. Bluestone, R. Gress, R. Hirsch, 1990, Transplantation.

Evidence that multiple residues on both the α-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor

D. Wiley, J. Bluestone, S. Nathenson, 1988, Cell.

Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells.

J. Bluestone, M. Eckhaus, R. Gress, 1989, Journal of immunology.

Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen.

M. Cooke, D. Lenschow, C. Goodnow, 1994, Journal of immunology.

Type 1 diabetes: translating mechanistic observations into effective clinical outcomes

J. Bluestone, Kevan C. Herold, Dario A. A. Vignali, 2013, Nature Reviews Immunology.

translating mechanistic observations into effective

J. Bluestone, Kevan C. Herold, Dario A. A. Vignali, 2022 .

Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis.

Nitin J. Karandikar, J. Bluestone, N. Karandikar, 1998, Journal of immunology.

Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer.

G. Boivin, J. Leiden, E. Giannini, 1998, Journal of immunology.

Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition

R. Dick, J. Bluestone, Stephen Jameson, 1992, The Journal of experimental medicine.

Structure and specificity of T cell receptor gamma/delta on major histocompatibility complex antigen-specific CD3+, CD4-, CD8- T lymphocytes

J. Bluestone, B. Houlden, M. Cotterman, 1988, The Journal of experimental medicine.

This information is current as Encephalomyelitis Control of Experimental Autoimmune Production by Regulatory T Cells and 92 Regulates IL-10 − microRNA-17

Jonathan H. Esensten, L. Jeker, Malika M. Morar, 2013 .

This information is current as Regulatory T Cells + CD 25 + Homeostasis of CD 4 Cutting Edge : CD 28 Controls Peripheral

S. Subudhi, K. Henriksen, A. J. Tooley, 2003 .

Effects of anti-CD3 monoclonal antibody on engraftment of T-cell-depleted bone marrow allografts in mice: host T-cell suppression, growth factors, and space.

J. Bluestone, K. Hiruma, R. Gress, 1992, Blood.

A single amino acid substitution in the alpha 3 domain of an H-2 class I molecule abrogates reactivity with CTL

J. Bluestone, T. Potter, T. Rajan, 1987, The Journal of experimental medicine.

Phenotypic and functional analysis of positive selection in the gamma/delta T cell lineage

J. Bluestone, J. Allison, L. Matis, 1993, The Journal of experimental medicine.

A protective role of gamma/delta T cells in primary infection with Listeria monocytogenes in mice.

K. Muramori, Ken Matsumoto, J. Bluestone, 2003 .

Murine gamma/delta-expressing T cells affect alloengraftment via the recognition of nonclassical major histocompatibility complex class Ib antigens.

J. Bluestone, B. Blazar, P. Taylor, 1996, Blood.

The Immune Tolerance Network at 10 years: tolerance research at the bedside

Laurence A. Turka, Jeffrey A. Bluestone, J. Bluestone, 2010, Nature Reviews Immunology.

Phase I evaluation of humanized OKT3: toxicity and immunomodulatory effects of hOKT3gamma4.

J. Bluestone, R. Zivin, J. Auger, 1999, Cancer research.

Reduced ultraviolet-induced carcinogenesis in mice with a functional disruption in B7-mediated costimulation.

J. Bluestone, T. Luger, S. Beissert, 1999, Journal of immunology.

CD43 is a murine T cell costimulatory receptor that functions independently of CD28

J. Bluestone, C. Thompson, R. Mosley, 1995, The Journal of experimental medicine.

T cell co-stimulation and in vivo tolerance.

J. Bluestone, D. Lenschow, J. Bluestone, 1993, Current opinion in immunology.

T cell inactivation and cytokine deviation promoted by anti-CD3 mAbs.

J. Bluestone, J. Smith, Judy A. Smith, 1997, Current opinion in immunology.

Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stages.

J. Zou, S. Ono, R. Wijesuriya, 1997, Cancer research.